Paragraf® announces Innovate UK Biomedical Catalyst grant award to develop the first proof of concept graphene-based diagnostic test to immediately identify patients who need an antibiotic treatment. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care...
Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces a plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care....
VectorBuilder Inc. – a leading provider of gene delivery solutions – has announced its plan to invest $30 million to build an ‘AAV Superbank’ for the research and drug discovery community. The company will develop a comprehensive collection of novel adeno-associated virus (AAV) capsids capable of targeting all the major tissues of therapeutic relevance, and deposit their sequences in the Superbank along with detailed biodistribution data. This bank will be made public, allowing free non-profit research use and license-based for-profit use...
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), has announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been doubled in response to the increasing market demand for OOC services as the technology gains traction within drug discovery and development programmes...
TESCAN ORSAY HOLDING a.s. announces the installation of the AMBER X focused ion beam-scanning electron microscope (FIB-SEM) at the Institute for Factory Automation and Production Systems (FAPS) in Germany. The AMBER X offers a unique combination of plasma FIB with ultra-high resolution (UHR) field emission SEM for multiscale materials characterization. FAPS is using the FIB-SEM for research that will help to improve products used in a wide variety of industries...
At Achema (Frankfurt August 22-26, 2022), Telstar will be promoting the latest innovative developments in both in line management devices and process analytical technology for pharmaceutical freeze-drying systems and aseptic manufacturing processes, together with integrated process equipment and laboratory integrated management systems. In the Laboratory field, Telstar will be promoting BiOptima IT, the first biological safety cabinet protected with ZEROCOAT, a new coating with an antimicrobial barrier proven to reduce cleaning and maintenance costs...
Azenta Life Sciences has expanded its current multiomics services to include Olink technology, which ensures robust, multiplex protein biomarker analysis of samples in a CAP/CLIA laboratory environment. Azenta has a global footprint offering an end-to-end solution, from sample procurement and storage to sample analysis, enabling biopharma companies to accelerate scientific research...
Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS?CoV?2 vaccine for European clinical trials. Vaccizone has developed and patented a novel method for delivering antigens and bioactive compounds which can increase the stability and shelf life of complex biotherapeutics, like vaccines...
For the 27th time, the Hamburg-based life sciences company Eppendorf SE is awarding its prestigious research prize this year. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Thi Hoang Duong Nguyen, MRC Laboratory of Molecular Biology, Cambridge, UK as the winner of the Eppendorf Award for Young European Investigators 2022....
Russell Green, Lead Product Manager for Drug Discovery and SynBio at Automata outlines the four biggest trends in lab automation. Around the world, labs are full of highly trained scientists eager to make breakthrough discoveries. However, tedious tasks and shallow levels of data are currently preventing them from utilising their knowledge to its fullest capacity. At SLAS Europe last month, it was evident that...
Agarose Bead Technologies (ABT), a key player in the life science industry, plans a major expansion of its manufacturing capabilities, tripling its production capacity to meet the global demand for agarose resins. With this significant investment, the company will be able to manufacture and deliver continuous supply of high-quality agarose resins to develop and implement cost-effective, robust, and scalable production processes supporting novel therapies worldwide including the mRNA based Covid-19 vaccines.
MolGen B.V. of Veenendaal (NL), a global solutions provider of hardware, reagents, consumables, software and service for human and animal diagnostics, the agriculture and biotech industries, participates in the American Association for Clinical Chemistry Fair (AACC) in Chicago on July 24th - 28th, 2022. The AACC Fair is one of the world’s most important international scientific and medical events for clinical laboratory technologies and research...
Merck, a leading science and technology company, has announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry is on a rolling transformation to evolve and digitalize the next generation of bioprocessing to increase accessibility and lower the cost of biologics...
Gene editing technique provides ability to switch genes on without adding transgenes. Rothamsted scientists have found a way to switch on a dormant gene without inserting foreign DNA and creating a GMO, as would usually be the approach. This is the first such demonstration using a gene editing ‘deletion’ approach in any organism, with previous methods not managing this feat in such a precise and predictable way...
Envair, a world leading manufacturer of isolators, laminar flow and microbiological safety cabinets for the healthcare, biotech and pharmaceutical industries, has been awarded a place on the HealthTrust Europe framework. The framework enables healthcare providers to make informed purchasing decisions that support the delivery of exceptional healthcare....
Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and laboratory analysis due to errors that take place before the sample arrives in the laboratory, such as sample collection, patient identification, sample handling, sample transportation, sample loss, etc.
Autoscribe Informatics has released a new case study focusing on how Matrix Gemini LIMS transformed AMS Testing and provided a solid quality framework for its metallurgical testing. Using the new LIMS avoids the need to manually collate and create final reports, enables the creation of quotes and invoices directly from the LIMS, and automatically generates management reports as required...
The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announce that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The BACF was created in 2005 to facilitate the characterization of biomolecules and their molecular interactions....
This new ‘MND Collaborative Partnership’ brings together people living with MND, charities LifeArc, MND Association, MND Scotland and My Name’5 Doddie Foundation, government bodies Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR), with researchers from King’s College London, University of Sheffield, University of Liverpool, University College London, University of Oxford and University of Edinburgh...
In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive challenges for the process industry. Which technologies can be used to achieve defossilisation? How to secure and enhance regional and global supply chain networks? And what hurdles must be overcome in the digitalisation of the industry? ACHEMA 2022 offers answers and solutions to these and many more questions...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in both San Francisco and Cambridge, is a company creation engine that partners with entrepreneurs to create genomics startups and advance innovative applications....
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses. The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with a consortium of research and technological institutions to develop a novel vaccine to provide protection against COVID-19 caused by current and future SARS-CoV-2 variants, as well as to protect against other SARS-like Betacoronaviruses...
Paragraf® announces Innovate UK Biomedical Catalyst grant award to develop the first proof of concept graphene-based diagnostic test to immediately identify patients who need an antibiotic treatment. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care...
Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces a plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care....
VectorBuilder Inc. – a leading provider of gene delivery solutions – has announced its plan to invest $30 million to build an ‘AAV Superbank’ for the research and drug discovery community. The company will develop a comprehensive collection of novel adeno-associated virus (AAV) capsids capable of targeting all the major tissues of therapeutic relevance, and deposit their sequences in the Superbank along with detailed biodistribution data. This bank will be made public, allowing free non-profit research use and license-based for-profit use...
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), has announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been doubled in response to the increasing market demand for OOC services as the technology gains traction within drug discovery and development programmes...
TESCAN ORSAY HOLDING a.s. announces the installation of the AMBER X focused ion beam-scanning electron microscope (FIB-SEM) at the Institute for Factory Automation and Production Systems (FAPS) in Germany. The AMBER X offers a unique combination of plasma FIB with ultra-high resolution (UHR) field emission SEM for multiscale materials characterization. FAPS is using the FIB-SEM for research that will help to improve products used in a wide variety of industries...
At Achema (Frankfurt August 22-26, 2022), Telstar will be promoting the latest innovative developments in both in line management devices and process analytical technology for pharmaceutical freeze-drying systems and aseptic manufacturing processes, together with integrated process equipment and laboratory integrated management systems. In the Laboratory field, Telstar will be promoting BiOptima IT, the first biological safety cabinet protected with ZEROCOAT, a new coating with an antimicrobial barrier proven to reduce cleaning and maintenance costs...
Azenta Life Sciences has expanded its current multiomics services to include Olink technology, which ensures robust, multiplex protein biomarker analysis of samples in a CAP/CLIA laboratory environment. Azenta has a global footprint offering an end-to-end solution, from sample procurement and storage to sample analysis, enabling biopharma companies to accelerate scientific research...
Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS?CoV?2 vaccine for European clinical trials. Vaccizone has developed and patented a novel method for delivering antigens and bioactive compounds which can increase the stability and shelf life of complex biotherapeutics, like vaccines...
For the 27th time, the Hamburg-based life sciences company Eppendorf SE is awarding its prestigious research prize this year. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Thi Hoang Duong Nguyen, MRC Laboratory of Molecular Biology, Cambridge, UK as the winner of the Eppendorf Award for Young European Investigators 2022....
Russell Green, Lead Product Manager for Drug Discovery and SynBio at Automata outlines the four biggest trends in lab automation. Around the world, labs are full of highly trained scientists eager to make breakthrough discoveries. However, tedious tasks and shallow levels of data are currently preventing them from utilising their knowledge to its fullest capacity. At SLAS Europe last month, it was evident that...
Agarose Bead Technologies (ABT), a key player in the life science industry, plans a major expansion of its manufacturing capabilities, tripling its production capacity to meet the global demand for agarose resins. With this significant investment, the company will be able to manufacture and deliver continuous supply of high-quality agarose resins to develop and implement cost-effective, robust, and scalable production processes supporting novel therapies worldwide including the mRNA based Covid-19 vaccines.
MolGen B.V. of Veenendaal (NL), a global solutions provider of hardware, reagents, consumables, software and service for human and animal diagnostics, the agriculture and biotech industries, participates in the American Association for Clinical Chemistry Fair (AACC) in Chicago on July 24th - 28th, 2022. The AACC Fair is one of the world’s most important international scientific and medical events for clinical laboratory technologies and research...
Merck, a leading science and technology company, has announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry is on a rolling transformation to evolve and digitalize the next generation of bioprocessing to increase accessibility and lower the cost of biologics...
Gene editing technique provides ability to switch genes on without adding transgenes. Rothamsted scientists have found a way to switch on a dormant gene without inserting foreign DNA and creating a GMO, as would usually be the approach. This is the first such demonstration using a gene editing ‘deletion’ approach in any organism, with previous methods not managing this feat in such a precise and predictable way...
Autoscribe Informatics has released a new case study focusing on how Matrix Gemini LIMS transformed AMS Testing and provided a solid quality framework for its metallurgical testing. Using the new LIMS avoids the need to manually collate and create final reports, enables the creation of quotes and invoices directly from the LIMS, and automatically generates management reports as required...
The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announce that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The BACF was created in 2005 to facilitate the characterization of biomolecules and their molecular interactions....
This new ‘MND Collaborative Partnership’ brings together people living with MND, charities LifeArc, MND Association, MND Scotland and My Name’5 Doddie Foundation, government bodies Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR), with researchers from King’s College London, University of Sheffield, University of Liverpool, University College London, University of Oxford and University of Edinburgh...
In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive challenges for the process industry. Which technologies can be used to achieve defossilisation? How to secure and enhance regional and global supply chain networks? And what hurdles must be overcome in the digitalisation of the industry? ACHEMA 2022 offers answers and solutions to these and many more questions...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in both San Francisco and Cambridge, is a company creation engine that partners with entrepreneurs to create genomics startups and advance innovative applications....
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses. The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with a consortium of research and technological institutions to develop a novel vaccine to provide protection against COVID-19 caused by current and future SARS-CoV-2 variants, as well as to protect against other SARS-like Betacoronaviruses...